NetworkNewsBreaks – Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) CEO Highlights Growth Strategy, India Expansion on BioMedWire Podcast
Cardio Diagnostics Holdings (NASDAQ: CDIO), took the spotlight in the latest episode of The BioMedWire Podcast, featuring CEO and Co-Founder Dr. Meesha Dogan discussing the company’s mission to improve cardiovascular disease prevention and early detection through precision medicine powered by epigenetics, genetics and artificial intelligence. During the interview, Dogan also highlighted Cardio Diagnostics’ expansion into India through partnerships with Aimil Ltd. and Dr. Lal PathLabs, as well as the company’s progress through the Medicare reimbursement process, noting that CPT coding and payment steps have been completed while coverage determination remains underway. To view the full press release, visit https://nnw.fm/cVUXn About Cardio Diagnostics Cardio Diagnostics is an artificial intelligence-powered precision…







